SDB-005 serves as an indazole-based synthetic cannabinoid that acts as an agonist for both CB1 and CB2 cannabinoid receptors. Often investigated within the context of designer drug research, this compound… Read more
SDB-005 serves as an indazole-based synthetic cannabinoid that acts as an agonist for both CB1 and CB2 cannabinoid receptors. Often investigated within the context of designer drug research, this compound requires rigorous analytical oversight to ensure accurate identification and quantification. The reference standards, impurities, and stable isotope labelled compounds in this category are essential for laboratories conducting comprehensive impurity profiling and method validation. Using high-quality analytical standards allows researchers to establish reliable protocols for the detection and characterization of this synthetic cannabinoid. Stable isotope labelled compounds are particularly valuable as internal standards in mass spectrometry-based assays, helping to mitigate matrix effects and improve precision during qualitative and quantitative analyses. By providing these materials, this collection supports the critical quality control and forensic assessment tasks necessary for studying the pharmacology and toxicological properties of synthetic cannabinoids in controlled laboratory environments.